Druggability & Clinical Context
Druggability
Low
Score: 0.50
Druggability Analysis
Structural Tractability0.30
Key Metrics
PDB Structures:
0
Known Drugs:
0
Approved:
0
In Clinical Trials:
0
Therapeutic Areas:neurodegeneration
Mechanism: Prioritized from 1 SciDEX hypotheses, including: Partial Neuronal Reprogramming via Modified Yamanaka Cocktail
Known Drugs:No known drugs targeting this protein